These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11160618)

  • 1. The binding-site crevice of the D4 dopamine receptor is coupled to three distinct sites of allosteric modulation.
    Schetz JA; Sibley DR
    J Pharmacol Exp Ther; 2001 Feb; 296(2):359-63. PubMed ID: 11160618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonconserved residues in the second transmembrane-spanning domain of the D(4) dopamine receptor are molecular determinants of D(4)-selective pharmacology.
    Schetz JA; Benjamin PS; Sibley DR
    Mol Pharmacol; 2000 Jan; 57(1):144-52. PubMed ID: 10617689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SH3 binding domains in the dopamine D4 receptor.
    Oldenhof J; Vickery R; Anafi M; Oak J; Ray A; Schoots O; Pawson T; von Zastrow M; Van Tol HH
    Biochemistry; 1998 Nov; 37(45):15726-36. PubMed ID: 9843378
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
    Schetz JA; Chu A; Sibley DR
    J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. I. NGD 94-1: identification of a novel, high-affinity antagonist at the human dopamine D4 receptor.
    Tallman JF; Primus RJ; Brodbeck R; Cornfield L; Meade R; Woodruff K; Ross P; Thurkauf A; Gallager DW
    J Pharmacol Exp Ther; 1997 Aug; 282(2):1011-9. PubMed ID: 9262370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Zn2+-binding site on the dopamine D2 receptor.
    Liu Y; Teeter MM; DuRand CJ; Neve KA
    Biochem Biophys Res Commun; 2006 Jan; 339(3):873-9. PubMed ID: 16332354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cluster of aromatic residues in the sixth membrane-spanning segment of the dopamine D2 receptor is accessible in the binding-site crevice.
    Javitch JA; Ballesteros JA; Weinstein H; Chen J
    Biochemistry; 1998 Jan; 37(4):998-1006. PubMed ID: 9454590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residues in the seventh membrane-spanning segment of the dopamine D2 receptor accessible in the binding-site crevice.
    Fu D; Ballesteros JA; Weinstein H; Chen J; Javitch JA
    Biochemistry; 1996 Sep; 35(35):11278-85. PubMed ID: 8784181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic and aromatic microdomains within the binding-site crevice of the D2 receptor: contributions of the second membrane-spanning segment.
    Javitch JA; Ballesteros JA; Chen J; Chiappa V; Simpson MM
    Biochemistry; 1999 Jun; 38(25):7961-8. PubMed ID: 10387039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human D(1), d(2(long)), d(2(short)), D(3) and D(4) dopamine receptors by amiloride and amiloride analogues.
    Hoare SR; Coldwell MC; Armstrong D; Strange PG
    Br J Pharmacol; 2000 Jul; 130(5):1045-59. PubMed ID: 10882389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cryptic initiation at the human D4 receptor reveals a functional role for the amino terminus.
    Schoots O; Sanyal S; Guan HC; Jovanovic V; Van Tol HH
    Biochemistry; 1996 Mar; 35(11):3614-8. PubMed ID: 8639513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of D2 dopamine receptors by amiloride and amiloride analogs.
    Hoare SR; Strange PG
    Mol Pharmacol; 1996 Nov; 50(5):1295-308. PubMed ID: 8913361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiloride derivatives and a nonpeptidic antagonist bind at two distinct allosteric sites in the human gonadotropin-releasing hormone receptor.
    Heitman LH; Ye K; Oosterom J; Ijzerman AP
    Mol Pharmacol; 2008 Jun; 73(6):1808-15. PubMed ID: 18344315
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D4/D2 receptor selectivity is determined by A divergent aromatic microdomain contained within the second, third, and seventh membrane-spanning segments.
    Simpson MM; Ballesteros JA; Chiappa V; Chen J; Suehiro M; Hartman DS; Godel T; Snyder LA; Sakmar TP; Javitch JA
    Mol Pharmacol; 1999 Dec; 56(6):1116-26. PubMed ID: 10570038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
    Lan H; Durand CJ; Teeter MM; Neve KA
    Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
    Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
    Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Certain 1,4-disubstituted aromatic piperidines and piperazines with extreme selectivity for the dopamine D4 receptor interact with a common receptor microdomain.
    Kortagere S; Gmeiner P; Weinstein H; Schetz JA
    Mol Pharmacol; 2004 Dec; 66(6):1491-9. PubMed ID: 15448188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine D2, D3, and D4 selective phenylpiperazines as molecular probes to explore the origins of subtype specific receptor binding.
    Ehrlich K; Götz A; Bollinger S; Tschammer N; Bettinetti L; Härterich S; Hübner H; Lanig H; Gmeiner P
    J Med Chem; 2009 Aug; 52(15):4923-35. PubMed ID: 19606869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fancy bioisosteres: metallocene-derived G-protein-coupled receptor ligands with subnanomolar binding affinity and novel selectivity profiles.
    Schlotter K; Boeckler F; Hübner H; Gmeiner P
    J Med Chem; 2005 Jun; 48(11):3696-9. PubMed ID: 15916420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
    Frändberg PA; Doufexis M; Kapas S; Chhajlani V
    Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.